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ABSTRACT OF THESIS

MODULATION OF VACCINE-INDUCED RESPONSES
BY ANTHELMINTIC TREATMENT IN PONIES
Vaccines and anthelmintics induce an inflammatory response in equids. Since they are
commonly given concurrently, it is practical to study any interaction between them. This
study evaluated whether IVM and PYR would modulate the acute phase inflammatory
response, the systemic gene expression of pro-inflammatory cytokines, and vaccinespecific titers induced by WNV, EHV, and KLH vaccines. Naturally-infected, yearling
ponies were sorted by gender, then fecal epgs. They were randomly assigned to three
treatment groups: IVM, PYR, and control. All ponies received vaccinations
intramuscularly on days 0 and 29. Whole blood, serum, and plasma samples were
collected 1, 3, and 14 days post-vaccination. Samples were analyzed for inflammatory
markers, cytokine, mRNA expression, and vaccine-specific IgG titers by ELISA. The
acute-phase inflammatory marker data showed no statistical significance; they did show
an increase in SAA, haptoglobin, and fibrinogen, and a decrease in iron after vaccination.
The mRNA data showed that anthelmintics had a significant effect on interleukin mRNA
levels, but not on TNF- or IFN- levels. The ELISA assays showed no biologically
significant reduction in IgG as compared to the control group. We conclude that
deworming does not affect vaccine IgG titers; therefore, ceasing vaccinating and
deworming concurrently is not necessary.
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1. Introduction
Intestinal invertebrate parasites of the horse, known as helminths, can alter the
immune response both locally and systemically (Betancourt et al. 2014, Davidson et al.
2005). Drugs targeting these multicellular organisms are known as anthelmintics; they are
commonly given to horses on the same day as routine vaccinations, such as for West Nile
virus and equine herpes rhinopneumonitis virus. Both anthelmintics and vaccines are
known to induce inflammation in horses (Steinbach et al. 2006, Andersen et al. 2012),
but studies into the effect of deworming on the systemic inflammatory response induced
by the vaccines has not been extensively studied.
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2. Background
Helminths are parasites that can be characterized into three main phyla:
Platyhelminthes (flukes and tapeworms) Nematoda (roundworms) and Acanthocephala
(thorny-headed worms) (Castro 1996). This thesis concentrates on the equine intestinal
nematode parasites known as the strongyles (order Strongylida), the largest order of
parasitic helminths in horses. The adults of family Strongylidae are identified by a welldeveloped buccal capsule and a copulatory bursa (Lichtenfels 1975). The adults can range
from 5 mm to 4.5 cm in length, with the males being smaller than the females
(Reinemeyer et al. 2007, Taylor et al. 2013). The family Strongylidae is further divided
into two subfamilies: the Strongylinae (large strongyles) and the Cyathostominae (small
strongyles), differentiated using the shape of their buccal capsule. The Strongylinae have
a funnel-shaped buccal capsule, while Cyathostominae have a cylindrical buccal capsule
(Lichtenfels 2008). The focus of the study described herein is the family Cyathostominae.
2.1 Cyathostominae
The cyathostomins are a family consisting of 13 morphologically different genera
that contain 51 species in total; 40 of these species are found in horses and ponies, while
the other 11 are only found in other equids (Lichtenfels et al. 2008). They are
microscopically similar to the large strongyles at their early stages (egg, first two larval
stages), but can be differentiated from the other Strongylida by their internal morphology
once they reach the third infective larval stage (Figure 1).
Figure 2.1- A third infective larval
stage of a cyathostomin; note the 8
intestinal cells, the sheath, the long
tail and the filariform esophagus.

2.2 Life cycle
Strongyle eggs are excreted from the horse via the feces, where they develop into
the first three larval stages (L1, L2, and L3) in the environment (Figure 2). Once the third
infective larval stage (L3) on the pasture is ingested by the horse, it penetrates into the
mucosal layer of the large intestine, where it develops into the early third larval stage
(EL3), late third larval stage (LL3) then the fourth larval stage (L4) and sometimes early
fifth stage (L5) before exiting the mucosa and developing into reproductive adults. The
exit of the cyathostomins into the intestinal lumen causes an inflammatory response,
2

exacerbated if the encysted stages (EL3, LL3 and L4) are induced to exit the mucosa by
the administration of fenbendazole (see section 2.4). The entire process from L3 ingestion
to finding eggs in the feces, also known as the prepatent period, ranges from six to eight
weeks for the first maturing species, if not interrupted by arrestment of EL3s (Ihler 2010,
Lyons 2011). Classification of the different stages is by morphology and location of the
stage, which is most efficient if the horse is necropsied. In this thesis, we will be
identifying the different strongyle species via microscopic observation of third-stage
larvae (Appendix B). Identification of the different species of strongyle is necessary to
determine the correct treatment regimen.
2.2.1. Effects of encysted L3 and L4 stages on the intestinal mucosa
The free-living L3 stage is able to survive on pasture for several months at a time;
once inside the horse, the EL3 stage can arrest within the mucosal tissue of the cecum
and ventral colon, emerging as early as one month and as late as three years after arrest.
(Gibson 1953, Reinemeyer and Nielsen 2012). In northern temperate climates of the U.S.,
the LL3s encyst in the mucosa in the fall, develop into L4s within the cyst over the
winter, and then emerge in the spring (Reinemeyer 1986). In most cases, these L4s
emerge from the mucosa into the lumen a small fraction of the population at a time,
causing diffuse necrotic swellings (Love et al. 1999).
(g)
(h)

(f)

(a)
(e)

(b)
(d)

(c)

Figure 2.2- Cyathostomin life cycle. Clockwise from (a) to (h): egg, larvated egg, L1,
L2, L3, EL3, L4, adult.
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If large numbers of larvae emerge synchronously, this causes mucosal cell rupture
accompanied by loss of fluid and proteins into the lumen, also known as protein-losing
enteropathy (Lyons et al. 1999, Steinbach et al. 2006). This greater damage causes a
massive inflammatory reaction in the mucosa, along with intestinal lesions. These effects,
in turn, can cause chronic diarrhea (Love et al. 1999, Peregrine et al. 2005). This
condition, called larval cyathostomiasis, can be severe enough to cause death of the horse
(Love et al. 1999). Although some horses may present with symptoms in the clinic, most
infected horses are asymptomatic.
Although a horse may not exhibit visible symptoms, an infection with
cyathostomins can cause hematological changes; in highly parasitized horses, these
changes can include low neutrophil counts, low serum albumin levels, anemia, and high
-globulin (Love et al. 1999). In addition, the horse will exhibit local cytokine release
associated with Th2 (IL-4 and IL-10) and Th1 (IFN- and TNF ) responses (Davidson et
al. 2005), with Th2 being the predominant response with non-filarial parasites. The Th1
response is more associated with the killing of intracellular pathogens and is involved
with the vaccine response (Berger 2000).
2.3. Anthelmintic types
Anthelmintics are classified based on their subcellular targets in the parasite.
Three different classes of anthelmintics are approved for use in equids to treat strongyles
in the United States: macrocyclic lactones, tetrahydropyrimidines, and benzimidazoles
(Holden-Dye and Walker 2007). We can test the efficacy of these compounds using the
equation in section 3.2.
2.3.1. Macrocyclic lactones
Macrocyclic lactones (MLs) such as ivermectin (IVM) and moxidectin (MOX) are
used to treat cyathostomin infections by paralyzing the body wall muscles of the worm,
specifically causing flaccid paralysis (Holden-Dye and Walker 2007, Claerebout and
Vercruysse 2012a). This paralysis is caused by the interaction of the drug with several
ligand-gated ion channels including nicotinic acetylcholine (nACh) receptors, ACh-gated
chloride channels, GABA-gated chloride channels, and histamine-gated chloride
channels. Of these various channels, it is their strong interaction with glutamate-gated
chloride channels that is the main method of action of the macrocyclic lactones (HoldenDye and Walker 2007). The paralyzed worm is then passed out of the horse via normal
peristalsis (Claerebout and Vercruysse 2012b). MLs are generally effective against
strongyles, but ascarids currently are mostly resistant to this class of drugs (Peregrine et
al. 2014). The current efficacy of a single dose of ivermectin (0.2 mg/kg IVM) against
strongyles in some studies is between 89% and 100% (Canever et al. 2013, Lester et al.
2013, Relf et al. 2014, Stratford et al. 2014). However, there are recent reports of reduced
activity of IVM and MOX against small strongyles in horses in several geographical sites
(Demeulenaere et al. 1997, Costa et al. 1998, Traversa et al. 2009, Lyons et al. 2011).
This is based on finding earlier returns of epgs after treatment compared initial activity
when MLs were first marketed. Critical tests recently have shown that activity on adult
small strongyles was still high but less on immature intestinal luminal stages; the result
being that the life cycle is shortened (Lyons et al. 2009).
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2.3.2. Tetrahydropyrimidines
Pyrantel pamoate (PYR) and pyrantel tartrate act as excitatory nACh receptor
agonists in the muscles lining the body wall of the small strongyle (Holden-Dye and
Walker 2007, Alverez et al. 2009). As an agonist, the drug binds competitively to the
nACh receptor and over-activates it. As a result, pyrantel causes spastic paralysis
(Holden-Dye and Walker 2007). As with the macrocyclic lactones, the paralyzed worm is
then passed out of the horse via normal peristalsis (Claerebout and Vercruysse 2012b).
Strongyles have a large range of resistance to pyrantel, with current single-dose (19
mg/kg) efficacy between 50% and 100% (Canever et al. 2013, Hsu and Martin 2013,
Lester et al. 2013, Relf et al. 2014, Stratford et al. 2014).
2.3.3. Benzimidazoles
Benzimidazoles affect the microtubular cytoskeleton of the parasite by binding to
-tubulin. This causes impaired movement and impaired reproductive ability of the
parasite (Holden-Dye and Walker 2007). Fenbendazole, the only benzimidazole approved
for larvicidal use globally, needs to be given at higher doses to eliminate those
cyathostomins which are encysted in the large intestinal mucosa (Claerebout and
Vercruysse 2012c). Currently, fenbendazole has between 0% and 84% efficacy against
luminal strongyles when given as a single dose (Canever et al. 2013, Lester et al. 2013,
Relf et al. 2014, Stratford et al. 2014). Unfortunately, when fenbendazole is given to a
horse in the larvicidal dose (10 mg/kg for 5 days), it triggers a local response by T
lymphocytes, eosinophils and macrophages, which surround L3 and L4 cyathostomins in
a thick granuloma. Within 4 to 6 days after fenbendazole treatment, the encysted larvae
die, releasing nematode waste products, to which intestinal eosinophils and lymphocytes
react, causing localized edema (Love et al. 1999). Within 2 weeks of treatment with the
larvicidal dose, morphological changes to the large intestine, including ulceration and
erosions into the mucosa, appear; these lesions can extend into the bowel wall (Steinbach
et al. 2006).
2.4. Intestinal response to anthelmintic treatment in the horse
Though anthelmintics are a necessary part of parasite control in the equid, they
can also trigger adverse reactions in the intestine as the adults are killed. These adverse
reactions include weight loss, diarrhea, subcutaneous edema and fever, a condition
known as larval cyathostomiasis (Love et al. 1999). In a study by Reid et al. (1995), they
used several statistical methods (student s t test, chi-square test and multiple logistic
regression analysis) to find the variables most likely to contribute to chronic diarrhea,
which they classified as larval cyathostomiasis; the effect of time since last anthelmintic
treatment (i.e. less than 2 weeks gave a higher score than anthelmintics given more
than two weeks prior to admittance to an equine hospital) was a significant contributor
(P=0.02) to the development of larval cyathostomiasis. The only other factors which were
of equal or higher significance were age (P=0.001) and season of diagnosis (P=0.02)
(Reid et al. 1995).
2.5. Anthelmintic resistance and herd management
The FDA defines anthelmintic resistance as the ability of a subset of parasites to
survive treatment with a specific anthelmintic to which they were previously susceptible
5

(USFDA-CVM 2013a). This phenomenon is due to changes in their genome and that of
their descendants. Resistance is determined by several factors, including the immune
status of the host animal and treatment protocols (USFDA-CVM 2013a). With regard to
detecting efficacy of the drug in a specific herd and therefore the level of parasite
resistance to the drug a fecal egg count reduction test (FECRT) is performed. The test
is performed on data taken from a group of animals and involves the calculation of the
percent reduction in the number of parasite eggs in a fecal sample between Day 0 and
Day 14 after treatment (USFDA-CVM 2013b). As recommended by Stratford et al.
(2014), any FECR found to be less than 90% indicates resistance is developing, or has
already developed, to the drug.
2.6. Immune modulation and inflammatory response to helminths
In humans, infecting parasites, such as Strongyloides stercoralis, induce
inflammation by releasing pathogen-associated molecular patterns (PAMPS). The PAMPs
regulate transcriptional activation of tumor necrosis factor (TNF- ), interleukin-1 (IL-1),
and interleukin-6 (IL-6), all of which are pro-inflammatory cytokines. If chronically
present, they can cause ulcerative colitis and inflammatory bowel disease (Berridge 2012,
Romero-Cabello et al. 2012).
Infection of helminths into tissues causes the initiation of the type 2 helper T cell
(Th2) inflammatory response; this response involves the recruitment and activation of
basophils, eosinophils, and mast cells (shown in Figure 3) (Koyasu and Moro 2011). Th2
cells are one of three types of CD4+ helper T cells; the other categories are the type 1
helper T (Th1) and type 17 helper T (Th17) cells (Zhu et al. 2010). Anti-inflammatory
cytokines, such as interleukin-25 and interleukin-33 (IL-25 and IL-33), are produced in
response to helminth infection by epithelial cells in the intestine. Their role is to induce
the blockage of helminth invasion of the mucosa until an adaptive response can be
initiated. In addition, IL-4 is produced by basophils and mast cells when stimulated by
the invading parasite and IL-6 is produced constitutively by natural helper cells, causing
antibody production and iron sequestration (Koyasu and Moro 2011).
Levels of non-heme iron transported by ferritin in the blood are used as marker of
inflammation by veterinary and human clinicians; when an inflammatory stress response
is triggered by the secretion of IL-6, it, in turn, induces the upregulation of the hormone
hepcidin. Hepcidin is a peptide that binds to an iron transport protein, ferroportin, in the
intestinal mucosa. When hepcidin is upregulated, ferroportin is downregulated, causing
iron withdrawal from the body and its subsequent sequestration, causing anemia (Johnson
and Wessling-Resnick 2012). In addition, this sequestration of iron restricts the parasites
access to the element, which is important in the function of redox enzymes, such as
NADH-fumerate reductase (NFR). This enzyme contains an iron-sulfur cluster as the
catalytic center and is responsible for the conversion of fumarate to succinate in the
helminth respiratory chain (Omura et al. 2001, Johnson and Wessling-Resnick 2012).
Helminth infection is known to block Th1 response activation, and instead
induces the activation of the Th2 response in rodents and immunocompromised humans
(Peón et al. 2013). The Th1 response is normally associated with infectious diseases
because of its induction of IFN-gamma (IFN- ) and tumor necrosis factor alpha (TNF- )
(Figure 3), which in turn stimulates phagocytosis and oxidative burst, as well as antigen
6

presentation to cytotoxic T cells (Spellberg and Edwards 2001, Davidson et al. 2005). In
contrast, Th2 responses are associated with IL-4 and IL-10 and cause antibody
production, B cell proliferation, and infiltration of eosinophils and basophils into the
tissues; this action leads to a more allergic response (Spellberg and Edwards 2001,
Davidson et al. 2005).
Davidson et al. (2005) published a study which explains the inflammatory
response to cyathostomins with regard to cytokine levels in naturally-infected horses.
Similar to aspects of the study described in this thesis, these cytokines were measured by
reverse transcriptase-competitive PCR (RT-cPCR) using the method described by
Guiguère and Prescott (1999). The reaction products were run on an agarose gel, and then
measured using densitometry, from which standard curves were graphed. All values were
normalized to -actin levels and expressed as fold change in cytokine mRNA expression
(Guiguère and Prescott 1999). However, unlike our study, Davidson et al. measured local
inflammation by taking mucosal samples of 6 sites in the intestine and measuring
cytokine and encysted larval burdens for each sample for all 17 horses. The study found
that increased IL-10 and IL-4 levels, therefore Th2 responses, are linked to the presence
of cyathostomins in the large intestinal wall, while IFN- was not associated with larval
parasite burdens. TNF- was only seen in those areas of the excised intestine which had
signs of mass excystment and/or empty cysts (Davidson et al. 2005).
Helminths, such as Schistosoma spp. and Trichinella spp., have been found to
modulate Th1 inflammatory responses in rodent and human subjects (Mangan et al. 2004,
McKay 2009, Walsh et al. 2009, Harn et al. 2009, Osborne et al. 2014); prior to the
current study, the modulation of inflammation by helminths in the horse has not been
studied. Previous studies in mice noted that interleukin-10 (IL-10) was the main cytokine
that contributed to protection against the Th2 response induced by infection (Mangan et
al. 2004, McKay 2009). For example, Mangan et al. (2004) found that Schistosoma
mansoni can induce the proliferation of B cells producing IL-10, which protects mice
from severe anaphylaxis. In a recent study by Osborne et al. (2014), they examined
whether Trichinella spiralis modulates the murine immune system by direct interaction or
by perturbing the natural gut microbiota. They found that a Type 2 T cell response was
induced and that the cytotoxic T cells specific to the virus given were not only decreased
in number, but also reduced in their effector functionality (i.e. stimulating the caspase
cascade leading to apoptosis of the target cell) when coinfected with the parasite (Harty et
al. 2000). In addition, they found that the helminths directly regulate antiviral T cell
responses, which could affect the efficacy of vaccines (Osborne et al. 2014).
Due to the helminths' ability to decrease inflammatory reactions in the intestine,
live helminths and helminth-derived proteins, such as those from Trichinella spp. have
been used therapeutically to decrease inflammation associated with inflammatory bowel
diseases, such as Crohn s (Motomura et al. 2008, Chu et al. 2013, Sandborn et al. 2013,
Hiemstra et al. 2014). Ironically, in addition to the helminths controlling the
inflammatory response in the intestine, one of the anthelmintic drugs used in these
studies, ivermectin, suppresses inflammation in rodent models by decreasing
immunoglobulin G (IgG) and decreasing infiltration of neutrophils, lymphocytes and
macrophages leading to a decrease in allergic inflammation, i.e. decreasing the Th2
response (Yan et al. 2011).
7

When the immune response is differentiated toward a Th2-type response during
helminth infection, B cells begin to produce immunoglobulin E (IgE) and
immunoglobulin G (IgG) in response to the release of IL-5 by eosinophils (Harris and
Gause 2011).
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Figure 2.3- The adaptive immune response to helminth infection with the pertinent cytokines and acute phase
proteins. Colored labels are the acute inflammatory markers commonly used in the veterinary clinic; the positive
signs mean that when inflammation is present, the systemic levels of these factors increase, while systemic iron
decreases with inflammation. Cytokines involved in the TH2 response are shown in red font; those which are
involved in the T H1 response are shown in green. Immune cells are shown in dark blue. Sources: Gause et al. 2013,
Koyasu and Moro 2011.

2.6.1. Acute inflammatory response to vaccination
Acute-phase proteins (APPs) are serum proteins originating in the liver that can
be used as a measure of levels of inflammation or infection (Eckersall 1995). The panel
of APPs used in quantification of the inflammatory response in the clinic is haptoglobin,
fibrinogen, and serum amyloid A (SAA). In addition to these three proteins, it is also
common to test serum iron levels as a marker of inflammation.
In a study by Andersen et al. (2012), ten horses were given, intramuscularly, an
immune stimulating complex (ISCOM) vaccine, specifically an inactivated
influenza/tetanus toxoid vaccine, or an adjuvanted, live recombinant vector vaccine
containing two influenza strains and tetanus toxoid. They found that serum SAA and
fibrinogen levels increased within 24 hours of injection with both vaccines, with elevated
inflammatory marker levels throughout the 96-hour study. As would be expected with the
SAA and fibrinogen level increases, there was a decrease in serum iron levels for 48
hours post-vaccination with both vaccines. Overall, the ISCOM vaccine gave a higher
inflammatory response than the vector vaccine. They concluded that vaccination is a
viable inducer of mild inflammation in the horse for study of the acute phase response.
2.6.2. Cytokine expression in response to vaccination
In addition to monitoring the inflammatory markers mentioned above,
inflammation can be monitored via leukocyte-produced cytokine levels and
hematological properties. The cytokines associated with the inflammatory Th2 vaccine
response in the horse are IL-4, IL-5, and IL-10, while IL-2, IFN- and TNF- are released
by Th1 cells after vaccination (Romagnani 1999). With the EHV vaccine we would
expect to see an increase in blood levels of IL-4, IL-5 and IL-10, while the WNV vaccine
would induce IFN- and/or TNF- release. The cytokines measured in this study (IL-1 ,
IL-4, IL-10, TNF- and IFN- ) are released at the highest level between at about 10 and
about 56 days after vaccination (Paillot et al. 2005, Kydd et al. 2006).
2.6.3. Hematological effects of vaccine and measuring vaccine antibody titers
Adjuvanted vaccines, such as the EHV and WNV vaccines in this study, or the
ISCOM vaccine in the Andersen et al. study described above, cause increases in total
WBC count, while protein vaccines have less of an effect on WBC levels (Andersen et al.
2012).
In addition to measuring cytokine levels and hematological features, the response
of the host immune system to the vaccine can be directly measured via antibody titers,
specifically different isotypes of IgG.
Four isotypes of IgG are commonly found in horse serum: IgG(a), IgG(b), IgG(c),
and IgG(T). IgG(a) and IgG(b) act via complement activation and opsonization (i.e. they
are cytophilic antibodies) and are associated with an acute inflammatory vaccine
response, while IgG(c) and IgG(T) act via competing with IgG(a) and IgG(b) for
antigens, with IgG(T) being associated with a more chronic inflammatory vaccine
response. Production of IgG(a) and IgG(b) is induced by the release of IFN- by Th1
cells, IgG(c) is associated with respiratory burst by peripheral leukocytes, and IgG(T)
release occurs with the end of active infection (Cunha et al. 2006, Lewis et al. 2008).
When vaccinated, IgG isotypes appear in the serum at different times post-inoculation:
IgG(c) appears first, IgG(a) appears at approximately 1 week, IgG(b) at approximately 3
weeks, and IgG(T) appears only after acute infection resolves, between 4 and 16 weeks
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post-inoculation (Cunha et al. 2006).
2.6.4. Modulation of inflammation by helminths and by anthelmintics
It is well established in large animals, both ruminant and horse, that vaccination
causes a potent inflammatory response, but modulation of this inflammatory response by
anthelmintics in horses is not as well defined (Killi 2008, Hepburn et al. 2009, Andersen
et al. 2012).
A recent study on the subject of modulation of inflammation by anthelmintics was
performed in calves (Schutz et al. 2012). They measured IL-4, IL-6, TNF- , and IFNlevels in calves after treatment with fenbendazole at one of two time points: 2 weeks prevaccination or at same time as vaccination. Another group of calves was given no
anthelmintic treatment but was vaccinated. When the calves were given the deworming at
the same time as they were vaccinated, there was a suppression by treatment on Th2
cytokine levels, specifically IL-4 levels. In addition, there was a decrease in parasite
burden. The decrease in Th1 response could influence the efficacy of the response against
repeat viral infection, i.e. decreased vaccine efficacy (Schutz et al. 2012). If this is true in
horses, then the vaccine efficacy should decrease with anthelmintic treatment.
The only previous study looking into the effect of removal of helminths on the
vaccination response in equids was published in 2001 by Edmonds et al. The study was
performed by dosing naturally-infected ponies with pyrantel pamoate (two doses, three
weeks apart) or moxidectin (one dose). Twenty-four days after the first treatment of
pyrantel or the dose of moxidectin, keyhole limpet hemocyanin (2 mg) was injected i.m.
Pre-treatment, 2 weeks and 4 weeks post-treatment blood samples were taken in order to
determine cytokine (IL-2, IL-4, IL-5, and IFN- ) and vaccine-induced antibody (IgA,
IgG(a), IgG(b), and IgG(T)) levels, and to determine the peripheral blood mononuclear
cell (PBMC) proliferation in response to two different stimulants (KLH and pokeweed
mitogen).The proliferation was measured as the mean count per minute for the stimulated
versus the unstimulated cells. At 4 weeks, the ponies were euthanized, and necropsied in
order to recover parasites (large and small strongyles, ascarids, and fly larvae) for
characterization and enumeration. They found that the parasitism level did affect the
KLH-induced cytokine response by PBMCs; ponies with fewer parasites had higher IL-4
and IFN- levels as compared to the non-vaccinated and heavily parasitized or the KLHvaccinated and moderately-to-highly parasitized ponies. There was no statistical
significance to the KLH-specific Ig levels, but the trend seemed to lean toward low
parasite-burdened ponies having higher total Ig and IgA levels at both two and four
weeks post-vaccination, while IgG(T) levels were higher for the less parasitized ponies at
two weeks only (Edmonds et al. 2001). These results suggest that removal of helminths,
as an effect of treatment, could increase the effectiveness of a vaccine when the horse is
challenged.
2.6.5. Parasite dynamic changes with equine host age
It has been established that the proportions of cyathostomin stages change as the
horse matures. As horses age, the production of pro-inflammatory cytokines such as IFNand TNF- increase in the peripheral blood (Adams et al. 2008, Hansen et al. 2013).
One previous study performed by Katepalli et al. (2008) used radioactive thymidine
incorporation to test the hypothesis that as horse telomeres shorten with PBMC division,
there will be a decline in immune function. They confirmed this hypothesis by finding
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that as telomeres shorten in PBMCs, the total serum IgG decreased and pro-inflammatory
cytokine expression increased.
Prior to the study by Katepalli, Chapman et al. (2003) studied the prevalence and
amount of cyathostomins in a range of ages of ponies. Previously untreated ponies
between the ages of 4 months and 5 years were naturally infected and fecal egg counts
were taken. At various times of the year, these ponies were necropsied and cyathostomins
were enumerated and classified as EL3, developing third stages in the mucosa, early
fourth stages still encysted in mucosa, luminal L4s or adults. The results showed that the
group with the highest percentage of EL3s was the 2 year olds, the L4s tended to make up
the highest percentage of cyathostomins in the 3 to 5 year-old pony lumens, and 1 year
olds had the highest number of adults in their intestinal lumen. The percentage of DLs
was, after considering the standard deviation, the same in all three age groups.
2.7 Knowledge gaps and how we fill them
Before this study, there were no studies which evaluated how the vaccination
response could be affected by the use of anthelmintics; this is a concern because foals are
commonly vaccinated and dewormed monthly for the first 12 months of life, with the
vaccinations and deworming occurring on the same day. In addition, as Th1 responses are
the selected for with most infections, and therefore vaccines, while deworming would
cause a shift toward a Th2 response (Nielsen et al. 2013). It is the aim of this study to
determine whether there is an interaction between the vaccine-induced inflammation and
the anthelmintic-induced inflammation which could affect vaccine response, either
increasing or decreasing that response.
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3. Experimental methodology
3.1 Aims and hypotheses
The study's main hypothesis is that any inflammation caused by vaccination, and
the vaccine efficacy, will be modulated by the administration of a concomitant
anthelmintic treatment. To test this hypothesis, we analyzed acute phase proteins and
cytokines in response to a combination of vaccinations, and, simultaneously, compared
the impact of the two anthelmintics on the vaccine response using ELISAs, inflammatory
markers, hematology and cytokine analyses.
Over 60 days in August and September 2013, a total of 23 female and intact male
ponies of approximately 8 months of age were involved in the study. The treatment
protocol included vaccination of all ponies with three separate vaccines: a protein vaccine
without adjuvant (keyhole limpet hematocyanin, KLH; 10 mg/kg for first dose, 5 mg/kg
for subsequent dose; Sigma, Saint Louis, MO), a live recombinant, adjuvanted vaccine
(West Nile virus, WNV; Recombitek rWNV, Merial; 1 mL/dose), and an inactivated viral
vaccine containing an Carbomer adjuvant (equine herpes rhinopneumonitis, EHV;
Prodigy with Havlogen, monovalent, Merck Animal Health; 2 mL/dose). Before
administration of vaccines and anthelmintics, the ponies were weighed using a platform
scale (model #700, Tru-Test Inc., Mineral Wells, TX). All vaccines were given i.m, and
each vaccine was given in one of three locations: the left side of the neck, the right side
of the neck and the pectoral region. All ponies were dosed two times, four weeks apart
with the vaccines. Concurrently, one cohort received, per oral, ivermectin (IVM;
Eqvalan, Merial; 200 g/kg, 8 ponies, Group A), a second received pyrantel pamoate
(PYR; Strongid Paste, Pfizer Animal Health; 6.6 mg base/kg, 8 ponies, Group B), and the
third cohort were kept untreated (Control, 7 ponies, Group C). At various time points
after each vaccination and anthelmintic treatment, we took blood and fecal samples from
all ponies. Blood was taken in order to analyze cytokine RNA levels (Tempus, Life
Technologies), inflammatory marker levels (BD Vacutainer® for serum, BD
Technologies, Durham, NC), to run vaccine titer analyses (BD Vacutainer® Plus Citrate
Tubes, BD Technologies, Durham, NC), and to do hematological counts (BD
Vacutainer® Plus K2 EDTA Tubes, BD Technologies, Durham, NC), such as white blood
cell counts, hematocrit and leukocyte subtyping. Feces were collected in order to find the
efficacy of the two anthelmintics in this cohort of ponies. The treatment and testing
protocols are displayed in Table 1.
Table 3.1-Experimental protocol by day number. "X" indicates the action taken that day.
-4
Vaccines
Anthelmintics
Whole blood
Feces

x*
x

0
x
x
x
x

1

3

4

14

x

x

x

x
x

Day
29 30
x
x
x
x
x
x

21

32

35

42

50

59

x

x
x

x

x

x

* On this day, only serum was taken.
3.2 Egg counts
In order to quantify efficacy of the two anthelmintics in the horses, fecal egg
counts (FECs) were performed. Feces were collected on the experimental days shown in
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Table 1. The sampling at Day -4 was performed in order to determine groupings for
dosing of the anthelmintics (see section 3.2 for more detail). Using the mini-FLOTAC
method, we were able to find the egg count per gram with a sensitivity of 5 eggs per gram
(epg) (Barda et al. 2013, Cringoli et al. 2010) (Figure 4; for further details, please see
Appendix A). After all counts were performed for all time points, a fecal egg count
reduction test (FECRT) was calculated against the pre-treatment counts for the strongyles
using the equation
FECR= 100*(FECDay 0 - FECDay 14)/FECDay 0
to determine the efficacy of the anthelmintics in each individual in the treatment groups
versus the ponies in the control group.
In addition to the FECs, the eggs were characterized based on morphology (i.e.
strongyle eggs were differentiated from ascarid and tapeworm eggs) (Zajac and Conboy
2012).
Figure 3.1. Setup of mini-FLOTAC
apparatus. Picture from Barda et al.
(2013).

3.3 Selection of groups
Grouping of ponies for treatment was based on the epg for Day -4 samples. The
ponies were sorted first by gender and then ranked by descending eggs per gram, i.e. have
equal numbers of low, medium, and high egg shedders in each group. After these
parameters were satisfied, the ponies were allocated to each group (1st pony was put into
group 1, the second was put into group 2, the third into group 3, etc.) The range of epg
was between 35 and 1725 strongyles. The anthelmintic type and distribution were as
follows (female, male): IVM (4,4); PYR (4,4) and Control (4,3).
3.4. Hematology
All hematological assays were performed by the University of Kentucky
Veterinary Diagnostic Laboratory. The following hematology tests were measured on
samples collected on the dates shown in Table 1: white blood cell (WBC) and red blood
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cell (RBC) counts, percentage of leukocytes (neutrophils, lymphocytes, basophils, and
monocytes), hematocrit, hemoglobin levels, and other RBC characteristics (mean
corpuscular hemoglobin, mean corpuscular volume, and mean corpuscular concentration)
using a Forcyte hematology analyzer (Oxford Science Inc., Oxford, CT).
3.5. Inflammatory markers
All inflammatory markers were measured using automated spectrophotometric
methods in the laboratory of Dr. Stine Jacobsen (Univ. of Copenhagen). Serum amyloid A
levels were measured using an immunoturbidometric assay (LZ SAA EIKEN,
EIKEN Chemical Co., Ltd., Shanghai, China), haptoglobin levels were measured using a
peroxidase assay (Phase Range Hp Assay, Tridelta Development, Ltd., Maynooth,
Ireland), fibrinogen levels were measured using the Clauss method on an automated
coagulometric analyzer, and iron levels were measured by colorimetric
spectrophotometry (ADVIA 1650, Siemens Healthcare, Erlangen, Germany) (Andersen
et al. 2014, Jacobsen et al. 2005a).
3.6. Cytokine expression
Blood was collected via venipuncture into Tempus tubes (Life Technologies,
Grand Island, NY) on the days outlined in Table 1. The samples were analyzed by
Alejandra Betancourt (Gluck Equine Research Center). RNA isolation was performed
using an iPrep Purification Instrument (Life Technologies, Grand Island, NY) and the
Purelink RNA isolation kit (Life Technologies, Grand Island, NY) as per the
manufacturer s instructions. RNase-free water was added to 1 g of isolated total RNA to
a volume of 41.5 L, and 38.5 L of MasterMix (16 L 5X AMV buffer, 16 L MgCl2, 4
L dNTP, 1 L RNasin and 0.5 LL of AMV reverse transcriptase) was added to each
sample. Reactions were incubated at 42°C for 15 minutes and 95°C for 5 minutes in a
Veriti 96-well thermocycler (Applied Biosystems, Foster City, CA) to form cDNA.
Intron-spanning equine cytokine-specific primer/probe sets were designed for analysis of
cDNA of the five cytokines (IL-1 , IL-4, IL-10, TNF- and IFN- ) (Assays-by-Design,
Applied Biosystems) using real-time PCR (ABI RT-PCR system, Applied Biosystems,
Foster City, CA) as described in Breathnach et al. (2006).
Relative quantification of cytokine expression changes were calculated using the
method, as described by Livak and Schmittgen (2001). Briefly, the cycle
threshold (CT) values from the real-time PCR instrument are imported into a graphing
program. The results are normalized to the endogenous control, -glucuronidase
(Betancourt et al. 2014). The results are given as the mean relative change in cytokine
gene expression (i.e. gene amplification) in each sample relative to the initial number of
cDNA molecules in the sample (i.e. RQ value), assumed as proxy for the cytokine levels
(Livak and Schmittgen 2001).
3.8. Vaccine ELISAs
KLH and EHV vaccine ELISAs were performed by Stephanie Reedy (Gluck
Equine Research Center), and WNV vaccine ELISAs were performed by Dr. Bettina
Wagner (Cornell University) in order to measure antigen-specific serum antibody levels
of whole IgG, IgG(a), IgG(b), and IgG(T). The 96-well microtiter plates were coated with
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300 g of KLH/well or with 50 g of 5 g/mL whole EHV-1 virus/well, and kept at 4°C
overnight. The sera samples were diluted in order to find the optimal concentration for
each IgG subtype. The control sera were 2-fold serially diluted to a final concentration of
7.81 EU/mL. A 1% polyvinyl alcohol (PVA) blocking solution, made in PBS, was diluted
1:1 with PBS and stored at room temperature until needed. The blocking solution stops
non-specific binding to the plastic. The secondary antibody was peroxidase-conjugated
AffiniPure Goat Anti-horse IgG (Jackson Immuno Research, West Grove, PA). When the
plates were ready, they were washed three times with PBS/TWEEN-20 (PBS-T) and 200
L of PVA blocking solution was added, and the plates incubated at RT for one hour. The
plates were washed three more times with PBS-T before 100 L of diluted serum samples
or standard was added to the appropriate wells in duplicate, and the plates incubated for
one hour at 37°C. The plates were washed three more times with PBS-T before 100 L of
secondary antibody was added and incubated for 1 hour at 37°C. The plates were washed,
and 100 L of SureBlue (KPL, Inc., Gaithersburg, MD) was added to the wells. Stop
Solution (KPL, Inc., Gaithersburg, MD) was added after 1 minute, and the plate was read
at 450 nm on a spectrophotometer (BioRad Benchmark Plus). The results were then
calibrated against the standard curve to determine relative ELISA units (ELISA units/mL)
(personal communication).
3.9. Statistical analyses
Mixed linear model analyses with repeated measures were performed using SAS
(version 9.3, SAS Institute Inc., Cary, NC, USA) to determine interactions between
cytokine expression, acute phase markers, vaccine IgGs, and egg counts (Table 4). The
random effect was the FEC and the class variables were group and time-point; the rest of
the variables were continuous. Interaction terms were calculated between group and time
and when time was found significant, a least square means analysis was used for a
Tukey s pairwise comparison of the time variable. A 5% significance level was used to
determine those parameters most affected.
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4. Results
4.1. Egg counts
The average fecal egg count reductions for each group are shown Table 2. A
negative number in the FECR table means that there was an increase in the levels
between Day 0 (treatment) and Day 14 in each month. Overall, we saw an average
efficacy of 96.8% with ivermectin, <1% efficacy with pyrantel, and an average increase
in egg counts of 13.2% in the control group.
Table 4.1- The observed efficacies of the two anthelmintics in the study cohort.

IVM
PYR
Control

Avg FECR-Aug
(%)
100.00 ± 0.00
53.51 ± 68.89
-25.03 ± 114.39

Avg FECR-Sept
(%)
93.51 ± 17.59
-55.43 ± 187.68
-1.55 ± 58.31

4.2. Hematology
As the graphs (Figure 5) indicate, the treatment groups had a 4.28-12% decrease
in total WBCs, a 2.47-3.25% increase in hematocrit, a 1.13-5.38% increase in
neutrophils, and a 0.42-3.72% decrease in lymphocytes within the first 5 days after the
first treatment. In contrast, the control group had a 15.2% decrease in total WBCs, a
2.51% increase in hematocrit, a 0.43% decrease in neutrophils, and a 1.00% decrease in
lymphocytes within the first 5 days after the first treatment. The second treatment had
similar effects to the first, except neutrophil percentages increased. In summary, there
were negligible changes in all of the hematology over the eight weeks.
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Figure 4.1- Hematological analysis results. Red= ivermectin; green=pyrantel pamoate;
blue=control. Error bars are the 95% confidence interval.
4.3. Inflammatory markers
As the graphs (Figure 6) indicate, there is a 55.9-133% increase in haptoglobin, a
21-40.1% increase in fibrinogen, a 2- to 45-fold increase in SAA, and a 4.0-23.9%
decrease in iron within the first 72 hours after the second treatment. There was a
statistical difference in the marker levels between the control and treatment groups for
fibrinogen, but not for SAA, haptoglobin or iron as determined by fixed effects analyses
(Table 3).

Figure 4.2- Acute phase marker analysis results. Red= ivermectin; green=pyrantel
pamoate; blue=control. Error bars are the 95% confidence intervals.
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4.4. Cytokine expression
With the use of mixed linear analyses and by looking at the graphs (Figure 7),
there are no statistically significant effects of time on IL-1 , IL-4, IL-10, and TNFlevels, but there is a significant statistical and biological decrease in IFN- mRNA levels
over time, specifically between days 29 and 32. In addition, we see that anthelmintic
treatment did have a statistically significant effect on the levels of IL-1 and IL-10, but
not on IL-4, TNF- or IFN- mRNA levels as determined by fixed effects analyses.

Figure 4.3- Cytokine expression results. Red= ivermectin; green=pyrantel pamoate;
blue=control. Error bars are the 95% confidence interval. Asterisks signify the timepoints
at which the groups had significant differences. Double asterisks signify where there was
a significant difference between timepoints.
4.5. Vaccine ELISAs
As seen in the graphs (Figures 8-10), there is an increase in all vaccine antibody
titers within 14 days post-vaccination, though the largest difference appears to be with the
WNV IgG(a) between Days 1 and 14, and between days 29 and 42 for KLH IgG(a) and
IgG(T) titers. The graphical results are consistent with the statistical difference in
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antibody titers for the three vaccines (Table 3). WNV antibody levels differ significantly
between days but neither cytokine expression nor inflammatory marker levels had an
effect. In addition, the IgG(a) levels were numerically higher in the WNV untreated
control group. KLH antibody levels differed not only between days, but they were also
affected by SAA, haptoglobin and IFN- levels. On the other hand, treatment did not
have an effect on the KLH titers. EHV antibody levels differed from day-to-day, but there
was no effect of treatment, cytokines or inflammatory markers on the EHV antibody
levels.

Figure 4.4- EHV vaccine titer ELISA results. Red= ivermectin; green=pyrantel pamoate;
blue=control. Error bars are the 95% confidence interval. ELISA units are defined as the
OD ratio (sample OD/cut-off OD). Double asterisks signify where there was a significant
difference between timepoints.
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Figure 4.5- WNV vaccine titer ELISA results. Red= ivermectin; green=pyrantel
pamoate; blue=control. Error bars are the 95% confidence interval. ELISA units are
defined as the OD ratio (sample OD/cut-off OD). Double asterisks signify where there
was a significant difference between timepoints.
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Figure 4.6- KLH vaccine titer ELISA results. Red= ivermectin; green=pyrantel pamoate;
blue=control. Error bars are the 95% confidence interval. ELISA units are defined as the
OD ratio (sample OD/cut-off OD). Double asterisks signify where there was a significant
difference between timepoints.
Table 4.2- Statistically significant (P 0.05) associations between day, group,
inflammatory markers and cytokine levels as calculated using a mixed linear model
analysis.
Response variable
SAA
Haptoglobin
Fibrinogen
Iron

Day/group
Day
Day, Group
Day, Group
Day

IL-1

Group

IL-4
IL-10
IFNTNFWNV
EHV
KLH
EPG

---Group
Day
---Day
Day, Group*Day
Day
----
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Inflammatory/immunologic
Fibrinogen, TNFIron, Fibrinogen, IL-10, IFNSAA, Haptoglobin
Haptoglobin, IL-10, IFNFibrinogen, Haptoglobin, IL-4, IL-10,
TNFHaptoglobin, IL-10
IL-4, IL-1
Haptoglobin, Iron, IL-10
SAA, Fibrinogen, IL-1
------SAA, Haptoglobin, IFNIron, IL-4, IL-10

5. Discussion
There were noteworthy effects of the administration of two different classes of
anthelmintics on several acute phase markers, cytokines, and vaccine titers. We will
discuss below those components which responded, both biologically and statistically, to
the administration of anthelmintics, and those that had little to no response to
anthelmintic treatment.
The acute-phase inflammatory marker data showed an increase in SAA,
haptoglobin, and fibrinogen after each vaccination. At these same time points, the serum
iron levels decreased, which is consistent with iron sequestration caused by induction of
inflammation (Wessling-Resnick 2010, Andersen et al. 2012). These results are similar to
data from Andersen et al. (2012). Their results showed that SAA and fibrinogen
concentrations increased while those of iron decreased after inflammatory stimulation
with both ISCOM and live recombinant vaccines (Andersen et al. 2012). In our study we
administered all three vaccines (KLH, WNV, and EHV) at the same time; even with this
difference, the results of the Andersen study and ours are similar: the overall trend, as
expected, is that there is a decrease in iron and an increase in acute phase protein levels.
Therefore, we can conclude that there was an inflammatory response to vaccination.
The cytokine expression data shows that anthelmintic treatment did have an effect
on the immune response to vaccination. In the Edmonds et al. (2001) study, they tested
whether immunity induced by KLH vaccination would be improved when the parasites
were removed. Their results were that moxidectin-treated ponies had significantly higher
levels of IL-4 than those that were treated with pyrantel. With pyrantel administration, the
ponies had increased IFN- levels as compared to the other groups. Neither IL-5 nor IL-2
changed with any treatment as compared to the control group. They concluded that the
decreased immune responses to KLH immunization may model the responses that may be
seen with other vaccines, meaning that vaccine effectiveness of the vaccines will be
diminished too (Edmonds et al. 2001). In comparison, our study showed a statistical
difference between the treatment groups and the control group for IL-1 , another proinflammatory and lymphoproliferative cytokine like IFN- , which suggests that there was
modulation of the inflammatory response as a result of treatment. Interestingly, there was
no statistically significant effect of treatment on IFN- or TNF- . Reasons for the
differences in cytokine expression between this study and Edmonds may be that 1)
treatment was separated from vaccination in the Edmonds study, 2) we measured gene
expression by extracting RNA directly from blood, while Edmonds study measured
cytokine levels after culturing PBMCs, and 3) the Edmonds study removed interaction
with the acute phase reaction by concentrating on the worm burden effects. As a
reminder, the Edmonds study set out to assess the effect of increasing numbers of
gastrointestinal parasites on immune response to vaccination. In addition, we did not
measure cytokine levels on the golden days of their release, as described in section
2.6.2.
The hematology results showed that the percentage of neutrophils increased after
each treatment. Previous studies involving intestinal inflammation found that
cyathostomin infection tends to cause short-term neutrophilia due to decreased neutrophil
turnover (Murphy and Love 1997). The increase in neutrophils is most likely a response
to vaccination, which we expect, and it is possible that any intestinal reaction to the
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worms or the treatment was overshadowed by the larger vaccine-associated inflammatory
response.
The ELISAs showed that there was no significant difference between treatment
and control groups, even when taking into consideration the high variability within the
herd in response to the vaccines. As a side note, it is likely that the ponies were already
exposed to EHV, because we see a larger increase in antibody levels by Day 1 but not at
Day 29. The lower KLH IgG titers throughout the study in comparison to the two
commercial vaccines were likely due to the lack of adjuvant in the protein vaccine and a
lack of previous exposure.
The egg count cannot be used as a measure of the number of adult worms in the
gastrointestinal tract; the accurate enumeration of adult worms is determined at necropsy.
Though fecal egg counts are inaccurate for enumerating adult worm burdens, the World
Association for the Advancement of Veterinary Parasitology (WAAVP) recommends this
method for evaluating anthelmintic efficacy (Coles et al. 1992). It is apparent from the
FECRT results that the ivermectin treatment was successful against strongyles after both
Day 0 and Day 29. During this study, the efficacy of pyrantel is diminished after both
treatment dates, suggesting that there is pyrantel resistance in this study cohort. As a
consequence of the lack of efficacy, therefore a decreased ability to kill the worms, these
ponies would most likely have a decreased local inflammatory response. As expected, the
pyrantel-treated ponies had low egg count reductions and the ivermectin-treated ponies
had >90% reductions, which is consistent with Lyons et al. (2008), in which they
reported that on several farms in Central Kentucky, pyrantel was only able to reduce the
strongyle egg count by an average of 27%, while ivermectin reduced strongyle egg
counts by 100%.
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6. Conclusions
The overarching conclusion of this study is that deworming does not affect
vaccine IgG titers, but there is an effect of treatment on vaccine-induced inflammatory
processes. Therefore, ceasing the practice of vaccinating and deworming on the same day
does not appear to be necessary at this time. In addition to the effect of deworming on
vaccine titers, we are able to determine whether ivermectin can act as an antiinflammatory; we cannot conclude that ivermectin can act as an anti-inflammatory within
the parameters of this study, since pyrantel and ivermectin treatments had similar
biological effects on fibrinogen.
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7. Future studies
As a follow-up to this study, I would follow Edmonds et al. s model to determine
the effect of the relative size of the parasite burden on the efficacy of a commercial
vaccine. In this project, we did not concentrate on the effect the cyathostomins on vaccine
efficacy, only the effect of the anthelmintics and the inflammatory reaction induced by
the dying parasites. In the case of the proposed study, I would use EHV because it has
been proven, not only in this study, but also in other studies, that of the three vaccines
used in this thesis study, it induces a more significant antibody response in the horse than
KLH or WNV (Patel et al. 2003, Van de Walle et al. 2010). In addition to the antibody
response to the vaccine, the inflammatory reaction induced by this vaccine would be an
increase in IFN- , signifying a pro-inflammatory response that would decrease with the
presence of the worms (Gildea et al. 2013). I would allocate the horses or ponies into two
groups: an ivermectin-treated group and an untreated group. Group size is determined
using G*Power 3.1 analysis software (Faul 2009), with an of 0.05 and a power of 0.40.
Using the EHV IgG(a) naïve vaccine titers data for the ivermectin group and the control
group from this thesis study, I am able to determine that we would need a total of 32
horses for the study, 16 per group. Pre-treatment and then every week after for three
weeks, fecals would be taken to determine the anthelmintic efficacy. We should see a
greater decrease in egg counts in the ivermectin group than the pyrantel group, and the
control should have the highest EPG. On the same day the horses are dewormed, but
before all participants receive a dose of EHV vaccine, blood will be taken to determine
pre-vaccination IgG levels. At two weeks and at one month later, blood would be taken
again to measure for vaccine-derived antibodies, along with IL-1, IL-10, IFN- , TNF- ,
IL-4, and the acute phase markers (haptoglobin, fibrinogen, SAA, and iron). This study is
useful because we can determine inflammatory effects for a single vaccine instead of all
three used in this study, and also, we are concentrating on the effect of the worms rather
than the treatment. If the parasites do have an effect on vaccine efficacy, then we should
see an increase in antibody titers with the treatment groups, with the ivermectin-treated
group having the highest levels of vaccine-derived antibodies.
We tested the effects of anthelmintics on inflammation in one year old ponies;
testing the influence of anthelmintics in equids >1 year of age would be logical because
as horses age, the production of pro-inflammatory cytokines such as IFN- and TNFincrease in the peripheral blood (Adams et al. 2008, Hansen et al. 2013). Repeating this
study in geriatric horses may be beneficial; as horses grow older, the immunological
reaction to strongyle infection changes, resulting in differences in egg shedding levels
and the number of cyathostomins found upon necropsy (Chapman et al. 2003, Lyons et
al. 2012, Wood et al. 2013). In addition, as mentioned earlier in this thesis, the total
serum IgG decreases and pro-inflammatory cytokine expression increases with age
(Katepalli et al. 2008).
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Appendix A: Quantitation of nematode eggs using the mini-FLOTAC method
We characterized and counted all eggs, but only carried out further quantitation and
calculations using strongyle egg counts. The mini-FLOTAC method involves the homogenization
of weighed 5± 0.1 grams of feces in 35±1 mL of flotation solution. The flotation solution was
made by adding 600 mL of tap water to a 2 liter container. To this was added 250 g of solid NaCl
(Amresco Corporation, Solon, Ohio) and 375 g of glucose monohydrate (Amresco Corporation,
Solon, Ohio). Water was then added to 1 L and allowed to stir at 80 degrees C until dissolution,
and then allowed to cool at room temperature. The resulting solution had a specific gravity equal
1.25. The mixture of feces and flotation solution in the Fill-FLOTAC was used to fill the two
flotation chambers (Mini-FLOTAC seen in Figure 2). After 10 ± 2 minutes, the reading disc was
rotated in order to make a single layer of eggs in each chamber. The two sides of the chamber
were counted and the eggs per gram were calculated from the sum of the counted eggs by
multiplying by 5.

Figure S1. Setup of larval culture in makeshift humidity chamber.
Picture courtesy of Holli Gravatte.
Appendix B: Culturing third-stage strongyle larvae from fecal samples
Setup of cultures
Using a modified version of Henriksen and Korsholm (1983), we cultured feces from Day 0 and
Day 60 in order to characterize the species of strongyles present in the samples. A humidity
chamber was made to ensure the cultures stayed moist. In order to set up the humidity chamber
for larval coprocultures, a plastic drinking cup approximately four inches in height was cut twothirds of the way from the top. Another cup was filled with 100 mL of water, and the upper part of
the cut cup was placed in the filled cup. The bottom of the cut cup was pierced with 4-5 holes in
order to allow air into the culture. An approximately 8 in x 8 in square of cheesecloth was held in
place to the water-filled cup by the open-ended part of the cut cup. Approximately 5 mL of water
was added drop-wise to the feces-vermiculite mixture to make a cohesive mass, which was added
to the cheesecloth. The cheesecloth was folded over the fecal mixture, and the bottom of the cut
cup with the holes was placed upside down to keep the cheesecloth in place. The cultures were
allowed to mature at 25°C in an incubator for 14 days, moistening the feces drop-wise directly
every 2 to 3 days after setup.
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Baermannizing
After 14 days of culturing, the larvae were collected using a modified Baermann
technique (Olsen et al. 2003). The Baermann technique for harvesting the larvae involves
attaching the cheesecloth-wrapped culture in its open-ended cup to a tea glass (Libbey Claret
Footed Iced Tea Glasses, Model # 89594) filled with tap water using large paperclips (Figure
S2). After the upper part of culture chamber was added to the glass, the cup filled with 100 mL of
water is scraped to ensure any larvae that have escaped into the water during culturing are added
to the apparatus. More tap water may have needed to be poured over the cheesecloth-wrapped
culture until the bottom of the cheesecloth was covered in about a centimeter of water. The
apparatus was left to sit at room temperature for 24 hours, at which point the cultures were
removed, and 5 mL of fluid from the bottom of the wineglass was collected in a 15 mL tube,
which was spun down 1140 x g* for 5 minutes in order to bring all larvae to the bottom. The
water was removed with a dropper to a volume of 2 mL and stored at 4°C until the cultures were
counted using nematode counting slides (Chalex Corporation, Grasonville, MD); the time of
delay to counting could be immediately after harvest to up to 2 weeks. Prior work in this
laboratory has determined that the ability of larvae to undergo heating is unchanged at 2 weeks
post-harvest, as described in Figure S3.

Figure S2. Setup of Baermann apparatus. Picture courtesy of Holli
Gravatte.
*conversion factor was found at www.sometechnology.com/pdfFiles/J_6B.pdf
Larval differentiation
The harvested, volume-reduced larval solution was mixed using a 5 mL disposable
transfer pipette in order to make the mixture homogeneous. Then, using the same pipette, the
entire 2 mL was taken up and added to the nematode slide. The slides were placed on a 55°C
hotplate for 3 minutes and 30 seconds in order to ensure the larvae were no longer motile. If the
larvae had continued motility, the slides were heated for an additional 30 seconds. The slides were
viewed at 10× under a halogen backlit binocular microscope (Nikon Eclipse 80i, Nikon Corp.,
Tokyo, Japan). The third stage larval differentiation was made based on number of intestinal cells,
presence of a visible cuticle, and shape of the esophagus. Even though there may be first and
second stage larvae in the culture, we can t differentiate between first or second stage strongyle
larvae.
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Figure S3-Differentiation of larvae grown in coprocultures. Identification is performed according
to Russell (1948).
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The larvae were characterized as seen in Table S1; the majority of larvae were found to
be third stage cyathostomins, identified by their 8 triangular intestinal cells, filariform esophagus,
sheath, and long tail (Figure 1). In addition, several Poteriostomum spp. and Strongylus vulgaris
were found using identification parameters defined by Zajac and Conboy (2012), as seen in
Figure S3.
Table S1- Larvae characterized in each sample at pre-trial and post-trial dates.
Pre-trial
Pony
M66
M67
M69
M71
M73
M74
M77
M78
M79
M81
M83
M85
M86
M88
M90
M91
M92

Cyathostomin
55
315
22
86
0
121
981
1
382
388
9
10
131
486
48
106
65

Poteriostomum
0
0
0
3
0
3
0
13
0
0
0
1
4
0
0
0
0

S. vulgaris
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
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Total
55
315
22
89
0
124
981
15
382
388
9
11
135
486
48
106
65

% cyathostomins
100.00
100.00
100.00
96.63
100.00
97.58
100.00
6.67
100.00
100.00
100.00
90.91
97.04
100.00
100.00
100.00
100.00

Post-trial
Pony
M66
M67
M69
M71
M73
M74
M77
M78
M79
M81
M83
M85
M86
M88
M90
M91
M92

Cyathostomin Poteriostomum
0
107
0
66
0
0
0
7
0
0
1
267
0
303
0
160
0
1
2
229
0
90
0
32
0
2
0
14
0
115
0
29
0
49

S. vulgaris
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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Total
107
66
0
7
0
268
303
160
1
231
90
32
2
14
115
29
49

% cyathostomins
100.00
100.00
100.00
100.00
100.00
99.63
100.00
100.00
100.00
99.13
100.00
100.00
100.00
100.00
100.00
100.00
100.00

Appendix C: Abbreviations
AMV= avian myeloblastosis virus
cDNA= complementary DNA
CT= cycle threshold; proportional to log of the concentration
CTRL= control
EHV= equine herpes rhinopneumonitis virus
epg= eggs per gram of feces
FEC= fecal nematode egg count
FECRT= fecal nematode egg count reduction test
GABA= gamma-aminobutyric acid
IFN- = interferon-gamma
IgG= immunoglobulin G
IL-1= interleukin 1
IL-4= interleukin 1
IL-10= interleukin 10
ISCOM= Immune Stimulating COMplex
IVM= ivermectin
KLH= keyhole limpet hemocyanin
L1= first larval stage
L2= second larval stage
L3= third larval stage; infective stage; on pasture
EL3= early third larval stage; in horse large intestine
LL3= late third larval stage; in horse large intestine
L4= fourth larval stage
L5= early fifth stage (adult)
nACh= nicotinic acetylcholine
NFR= NADH-fumerate reductase
PBMC= peripheral blood mononuclear cell
PYR= pyrantel pamoate
SAA= serum amyloid A
Th1= type 1 helper T-cell
Th2= type 2 helper T-cell
TNF- = tumor necrosis factor alpha
WNV= West Nile virus

34

References
Adams, A.A., et al. (2008) Advanced age in horses affects divisional history of T cells
and inflammatory cytokine production. Mech. Ageing Dev. 129, 656-664.
Alverez, L. I., et al. (2009) Formulations, Dosages, and Routes of Administration.
Veterinary Pharmacology and Therapeutics. J. E. Riviere and M. G. Papich.
Ames, Iowa, John-Wiley and Sons, 1081.
Andersen, S. A., et al. (2012) Vaccination elicits a prominent acute phase response in
horses. Vet. J. 191, 199-202.
Andersen, U.V. et al. (2014) Physiologic and systemic acute phase inflammatory
responses in young horses repeatedly infected with cyathostomins and Strongylus
vulgaris. Vet. Parasitol. 201, 67-74.
Barda, B.D. et al. (2013) Mini-FLOTAC, an Innovative Direct Diagnostic Technique for
Intestinal Parasitic Infections: Experience from the Field. PLoS Neg. Trop. Dis. 7,
e2344.
Berger, A. (2000) Th1 and Th2 responses: what are they? BMJ 321, 424.
Berridge, M. J. (2012) Module 11: Cell Stress, Inflammatory Responses and Cell Death.
Cell Signaling Biology, 1-29.
Betancourt, A., et al. (2014) Characterisation of the inflammatory cytokine response to
anthelmintic treatment in ponies. Equine Vet. J. Epub ahead of print.
Breathnach, C.C. et al. (2006) Foals are interferon gamma-deficient at birth. Vet.
Immunol. Immunopathol. 112, 199-209.
Canever, R. J., et al. (2013) Lack of Cyathostomin sp. reduction after anthelmintic
treatment in horses in Brazil. Vet. Parasitol. 194: 35-39.
Castro, G. A., Ed. (1996) Chapter 86 Helminths: Structure, Classification, Growth, and
Development. Medical Microbiology. Galveston, TX, University of Texas
Medical Branch at Galveston.
Chapman, M.R. et al. (2003) Prevalence of strongyle nematodes in naturally infected
ponies of different ages during different seasons of the year in Louisiana. J.
Parasitol. 89, 309-314.
Chu, K.M. et al. (2013) Childhood Helminth Exposure Is Protective Against
Inflammatory Bowel Disease: A Case Control Study in South Africa. Inflamm.
Bowel Dis. 19, 614-620.
Claerebout, E. and J. Vercruysse (2012a) Macrocyclic Lactones. . In: Aiello, S.E.,
Moses, M. (Eds.) The Merck Veterinary Manual (online version). Merck Sharpe
& Dohme Corp., Whitehouse Station, NJ.
Claerebout, E. and J. Vercruysse (2012b) Mechanisms of Action of Anthelmintics.
In: Aiello, S.E., Moses, M. (Eds.) The Merck Veterinary Manual (online version).
Merck Sharpe & Dohme Corp., Whitehouse Station, NJ.
Claerebout, E., Vercruysse, J. (2012c) Benzimidazoles, In: Aiello, S.E., Moses, M.
(Eds.) The Merck Veterinary Manual (online version). Merck Sharpe & Dohme
Corp, Whitehouse Station, NJ.
Coles, G.C. et al. (2006) The detection of anthelmintic resistance in nematodes of
veterinary importance. Vet. Parasitol. 136, 167-185.

35

Costa, A.J., Barbosa, O.F., Moraes, F.R., Acuna, A.H., Rocha, U.F., Soares, V.E.,
Paullilo, A.C., Sanches, A. (1998) Comparative efficacy evaluation of moxidectin
gel and ivermectin paste against internal parasites of equines in Brazil. Vet.
Parasitol. 80, 29-36.
Cringoli, G. et al. (2010) FLOTAC: new multivalent techniques for qualitative and
quantitative copromicroscopic diagnosis of parasites in animals and humans. Nat.
Protoc. 5, 503-515.
Cunha, C.W. et al. (2006) Development of Specific Immunoglobulin Ga (IgGa) and IgGb
Antibodies Correlates with Control of Parasitemia in Babesia equi Infection. Clin.
Vaccine Immunol. 13, 297-300.
Davidson, A. J., et al. (2005) Cytokine responses to Cyathostominae larvae in the equine
large intestinal wall. Res. Vet. Sci. 78, 169-176.
Demeulenaere, D., Vercruysse, J., Dorny, P., Claerebout, E. (1997) Comparative studies
of ivermectin and moxidectin in the control of naturally acquired cyathostome
infections in horses. Vet. Rec. 141, 383-386.
Eckersall, P.D. (1995) Acute phase proteins as markers of inflammatory lesions. Comp.
Haematol. Int. 5, 93-97.
Edmonds, J.D. et al. (2001) Altered immune responses to a heterologous protein in
ponies with heavy gastrointestinal parasite burdens. Equine Vet. J. 33, 658-663.
Faul, F. et al. (2009) Statistical power analyses using G*Power 3.1: Tests for correlation
and regression analyses. Behav. Res. Methods 41, 1149-1160.
Gause, W.C. et al. (2013) Type 2 immunity and wound healing: evolutionary refinement
of adaptive immunity by helminths. Nat. Rev. Immunol. 13, 607-614.
Gibson, T.E. (1953) The Effect of Repeated Anthelmintic Treatment with Phenothiazine
on the Faecal Egg Counts of Housed Horses, with Some Observations on the Life
Cycle of Trichonema spp. in the Horse. J. Helminthol. 27, 29-40.
Gildea, S. et al. (2013) Humoral response and antiviral cytokine expression following
vaccination of thoroughbred weanlings A blinded comparison of commercially
available vaccines. Vaccine 31, 5216-5222.
Guguère, S. and Prescott, J.F. (1999) Quantitation of equine cytokine mRNA expression
by reverse transcription-competitive polymerase chain reaction. Vet. Immunol.
Immunopathol. 67, 1-15.
Hansen, S. et al. (2013) Age-related changes in intracellular expression of IFN- and
TNF- in equine lymphocytes measured in bronchoalveolar lavage and peripheral
blood. Dev. Comp. Immunol. 39, 228-233.
Harn, D.A. et al. (2009) Modulation of host immune responses by helminth glycans.
Immun. Rev. 230, 247-257.
Harris, N. and Gause, W.C. (2011) B cell function and immune response to helminths.
Trends Parasitol. 32, 80-88.
Harty, J.T., et al. (2000). CD8+ T Cell Effector Mechanisms in Resistance to Infection.
Annu. Rev. Immun. 18, 275-308.
Henriksen, S.A. and Korshalm, H. (1983) A method for culture and recovery of
gastrointestinal strongyle larvae. Nord. Vet. Med. 35, 429-430.

36

Hepburn, J.J. et al. (2009) Technical note: Copper chaperone for copper, zinc superoxide
dismutase: A potential biomarker for copper status in cattle. J. Anim. Sci. 87,
4161-4166.
Hiemstra, I.H. et al. (2014) Excreted/secreted Trichuris suis products reduce barrier
function and suppress inflammatory cytokine production of intestinal epithelial
cells. Mol. Immunol. 60, 1-7.
Holden-Dye, L. and R. J. Walker (2007) Anthelmintic drugs. WormBook 1-13.
Hopster-Iversen, C. et al. (2011) Influence of mechanical manipulations on the local
inflammatory reaction in the equine colon. Equine Vet. J. Suppl. 43, 1-7.
Ihler, C.F. (2010) Anthelmintic resistance. An overview of the situation in the Nordic
countries. Acta Vet. Scand. 52, S24.
Hsu, W. H. and R. J. Martin (2013). Chapter 16- Antiparasitic Agents. Handbook of
Veterinary Pharmacology, 379-412.
Jacobsen, S. et al. (2005) Use of serum amyloid A and other acute phase reactants to
monitor the inflammatory response after castration in horses: a field study. Equine
Vet. J. 37, 552-556.
Johnson, E. E. and M. Wessling-Resnick (2012) Iron metabolism and the innate immune
response to infection. Microbes Infect. 14, 207-217.
Katepalli, M.P. et al. (2008) The effect of age and telomere length on immune function in
the horse. Dev. Comp. Immunol. 32, 1409-1415.
Killi, R. (2008) Assessment of the Ability of Two Differently Constructed Equine Viral
Vaccines to Induce Systemic Inflammation. University of Georgia, Athens,
Georgia.
Koyasu, S. and K. Moro (2011). Type 2 innate immune responses and the natural helper
cell. Immunology 132, 475-481.
Krista, K.M. et al. (2013) Evaluation of neutrophil apoptosis in horses with acute
abdominal disease. Am. J. Vet. Res. 74, 999-1004.
Kydd, J.H., Townsend, H.G.G., Hannant, D. (2006) The equine immune response to
equine herpesvirus-1: The virus and its vaccines. Vet. Immunol. Immunop. 111,
15-30.
Lester, H. E. and J. B. Matthews (2013) "Faecal worm egg count analysis for targeting
anthelmintic treatment in horses: Points to consider." Equine Vet. J. 46, 139-145.
Lewis, M.J. et al. (2008) The different effector function capabilities of the seven equine
IgG subclasses have implications for vaccine strategies. Mol. Immunol. 45, 818827.
Lichtenfels, J.R. (1975) Helminths of Domestic Equids: Illustrated Keys to Genera and
Species with Emphasis on North American Forms. P. Helm. Soc. Wash. 42, 1-78.
Lichtenfels, J. R., et al. (2008) Illustrated identification keys to strongylid parasites
(strongylidae: Nematoda) of horses, zebras and asses (Equidae). Vet. Parasitol.
156, 4-161.
Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data
Using Real-Time Quantitative PCR and the 2- CT Method. Methods 25, 402-408.
Love, S., et al. (1999) Pathogenicity of cyathostome infection. Vet. Parasitol. 85, 113122.

37

Lyons, E. T., et al. (1999) Historical perspective of cyathostomes: prevalence, treatment
and control programs. Vet. Parasitol. 85, 97-112.
Lyons, E. T., et al. (2008) Evaluation of parasiticidal activity of fenbendazole,
ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on
ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky
in 2007. Parasitol. Res. 103, 287-291.
Lyons, E.T., et al. (2009) Probable reason why small strongyle EPG counts are returning
early after ivermectin treatment of horses on a farm in Central Kentucky.
Parasitol. Res. 104, 569-574.
Lyons, E.T., et al. (2011) Field tests demonstrating reduced activity of ivermectin and
moxidectin against small strongyles in horses on 14 farms in Central Kentucky in
2007-2009. Parasitol. Res. 108, 355-360.
Lyons, E. T., et al. (2011) Observations on development of natural infection and species
composition of small strongyles in young equids in Kentucky. Parasitol. Res. 109,
1529-1535.
Lyons, E.T. et al. (2012) Investigation of strongyle EPG values in horse mares relative to
known age, number positive, and level of egg shedding in field studies on 26
farms in Central Kentucky (2010-2011). Parasitol. Res. 110, 2237-2245.
Mangan, N.E. et al. (2004) Helminth Infection Protects Mice from Anaphylaxis via IL10-Producing B Cells. J. Immunol. 173, 6346-6356.
McCulloch, J., Williamson, S.A., Powis, S.J., Edington, N., 1993. The effect of EHV-1
infection upon circulating leucocyte populations in the natural equine host. Vet.
Microbiol. 37, 147-161.
McKay, D.M. (2009) The therapeutic helminth? Trends Parasitol. 25, 109-114.
Motomura, Y. et al. (2008) Helminth antigen-based strategy to ameliorate inflammation
in an experimental model of colitis. Clin. Exp. Immunol. 155, 88-95.
Nielsen, M.K., Chambers, T., Horohov, D.W., Jacobsen, S. (2013). The interaction
between anthelmintic treatment and vaccination (University of Kentucky and
University of Copenhagen), pp. 1-36.
Olsen, S.N. et al. (2003) Recovery of live immature cyathostome larvae from the faeces
of horses by Baermann technique. Vet. Parasitol. 116, 259-263.
Omura, S., et al. (2001) An anthelmintic compound, nafuredin, shows selective inhibition
of complex I in helminth mitochondria. PNAS 98, 60-62.
Osborne, L.C., et al. (2014) Virus-helminth coinfection reveals a microbiota-independent
mechanism of immunomodulation. Science 345, 578-582.
Paillot, R. et al. (2005) Equine interferon gamma synthesis in lymphoytes after in vivo
infection and in vitro stimulation with EHV-1. Vaccine 23, 4541-4551.
Patel, J.R. et al. (2003) Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy
against respiratory diseases following EHV types 1 and 4 challenges. Vet.
Microbiol. 92, 1-17.
Peón, A. N., et al. (2013) Immunoregulation by Taenia crassiceps and Its Antigens.
BioMed Res. Int. 2013, 1-13.
Peregrine, A. S., et al. (2005) Larval cyathostominosis in horses in Ontario: An emerging
disease? Can. Vet. J. 46, 80-82.

38

Peregrine, A. S., et al. (2014) Anthelmintic resistance in important parasites of horses:
Does it really matter? Vet. Parasitol. 201, 1-8.
Romagnani, S. (1999) Th1/Th2 cells. Inflamm. Bowel Dis. 5, 285-94.
Reid, S.W.J. et al. (1995) Epidemiological risk factors associated with a diagnosis of
clinical cyathostominosis in the horse. Equine Vet. J. 27, 127-130.
Reinemeyer, C. R. (1999) Current concerns about control programs in temperate
climates. Vet. Parasitol. 85, 163-172.
Reinemeyer, C.R., et al. (2007) Nematodes. Equine Infectious Diseases. D. C. Sellon and
M. T. Long. St. Louis, Saunders Elsevier: 80-90.
Reinemeyer, C.R. and Nielsen, M.K. (2012) Handbook of Equine Parasite Control, 1st
edn., Wiley-Blackwell, Hoboken, NJ.
Relf, V.E. et al. (2014) Anthelmintic efficacy on UK Thoroughbred stud farms. Int. J.
Parasitol. 44, 507-514.
Romero-Cabello, R. et al. (2012) Hyperinfection with Strongyloides stercoralis. BMJ
Case Rep. 2012.
Russell, A.F. (1948) The Development of Helminthiasis in Thoroughbred Foals. J. Comp.
Pathol. Therap. 58, 107-127.
Sandborn, W.J. et al. (2013) Randomised clinical trial: the safety and tolerability of
Trichuris suis ova in patients with Crohn s disease. Aliment. Pharmacol. Ther. 38,
255-263.
Schutz, J.S. et al. (2012) Effects of gastrointestinal parasites on parasite burden, rectal
temperature and antibody titer responses to vaccination and infectious bovine
rhinotracheitis virus challenge. J. Anim. Sci. 90, 1948-1954.
Spellberg, B. and Edwards, J.E. (2001) Type 1/Type 2 Immunity in Infectious Diseases.
Clin. Infect. Dis. 32, 76-102.
Steinbach, T., et al. (2006) Small strongyle infection: Consequences of larvicidal
treatment of horses with fenbendazole and moxidectin. Vet. Parasitol. 139: 115131.
Stratford, C. H., et al. (2014) An investigation of anthelmintic efficacy against strongyles
on equine yards in Scotland. Equine Vet. J. 46: 17-24.
Taylor, M.A., Coop, R.L., Wall, R.L. (2013) Veterinary Parasitology, 3rd Edition.
Blackwell Publishing, Oxford, UK.
Traversa, D., Samson-Himmelstjerna, G.v., Demeler, J., Milillo, P., Schurmann, S.,
Barnes, H., Otranto, D., Perrucci, S., Regalbono, A.F.d., Beraldo, P., Boeckh, A.,
Cobb, R. (2009) Anthelmintic resistance in cyathostomin populations from horse
yards in Italy, United Kingdom and Germany. Parasite. Vector. 2, S2.
Urban, Jr., J.F., et al. (2007) Infection with parasitic nematodes confounds vaccination
efficacy. Vet. Parasitol. 148: 14-20.
U.S. Food and Drug Administration (2013a) Antiparasitic Resistance. Retrieved 19
March, 2014.
U.S. Food and Drug Administration (2013b) Antiparasitic Resistance in Cattle and Small
Ruminants in the United States: How to Detect It and What to Do About It.
Retrieved 19 March, 2014.

39

Van de Walle, G.R. et al. (2010) A vectored equine herpesvirus type 1 (EHV-1) vaccine
elicits protective immune responses against EHV-1 and H3N8 equine influenza
virus. Vaccine 28, 1048-1055.
Walsh, K.P., et al. (2009) Infection with a Helminth Parasite Attenuates Autoimmunity
through TGF-beta-mediated Suppression of Th17 and Th1 Responses. J.
Immunol. 183, 1577-1586.
Wesseling-Resnick, M. (2010) Iron Homeostasis and Inflammatory Response. Annu. Rev.
Nutr. 30, 105-122.
Wood, E.L. et al. (2013) Variation in fecal egg counts in horses managed for
conservation purposes: individual egg shedding consistency, age effects and
seasonal variation. Parasitology 140, 115-128.
Yan, S. et al. (2011) Anti-inflammatory effects of ivermectin in mouse model of allergic
asthma. Inflamm. Res. 60, 589-596.
Zajac, A.M. and Conboy, G.A. (2012) Helminth ova and protozoan cysts as found in
freshly voided feces of horses. In: Veterinary Clinical Parasitology, 8th edn.,
John-Wiley and Sons, Ames, Iowa. pp 115-127.
Zhu, J., et al. (2010). Differentiation of Effector CD4 Cell Populations. Annu. Rev.
Immunol. 28, 445-489.

40

EMILY F. RUBINSON

EDUCATION
Smith College, Northampton, MA, August 2005-May 2009, BA, Biochemistry.
Georgetown University, Washington, DC, June-August 2008, no degree awarded.
George Washington University, Washington, DC January 2011-May 2012, no degree
awarded.
University of Kentucky, Lexington, KY, September 2012-present, M.S. to be awarded
December 2014.
POSITIONS HELD
Graduate Research Assistant, Department of Microbiology, Immunobiology and
Molecular Genetics/Department of Veterinary Science, University of Kentucky,
Lexington, KY (July 2013-present)
Volunteer Laboratory Technician, Department of Chemistry, Georgetown University,
Washington, DC (September 2010-September 2011)
CQL Program Participant, Department of Molecular Pathology, Walter Reed Army
Institute of Research, Silver Spring, MD (Summers 2006 and 2007)
Volunteer Lab Technician, Department of Biochemistry, Georgetown University,
Washington, DC (Summer 2004 and January 2006)
PUBLICATIONS
Nielsen, M.K., Vidyashankar, A.N., Bellaw, J., Gravatte, H.S., Cao, X., Rubinson, E.F.,
Reinemeyer, C.R. (2014) Serum Strongylus vulgaris-specific antibody responses to
anthelmintic treatment in naturally infected horses. Parasitol Res. 2014 Oct 31. [Epub
ahead of print].

41

